Unknown

Dataset Information

0

Diagnosis and Risk Prediction of Dilated Cardiomyopathy in the Era of Big Data and Genomics.


ABSTRACT: Dilated cardiomyopathy (DCM) is a leading cause of heart failure and life-threatening ventricular arrhythmias (LTVA). Work-up and risk stratification of DCM is clinically challenging, as there is great heterogeneity in phenotype and genotype. Throughout the last decade, improved genetic testing of patients has identified genotype-phenotype associations and enhanced evaluation of at-risk relatives leading to better patient prognosis. The field is now ripe to explore opportunities to improve personalised risk assessments. Multivariable risk models presented as "risk calculators" can incorporate a multitude of clinical variables and predict outcome (such as heart failure hospitalisations or LTVA). In addition, genetic risk scores derived from genome/exome-wide association studies can estimate an individual's lifetime genetic risk of developing DCM. The use of clinically granular investigations, such as late gadolinium enhancement on cardiac magnetic resonance imaging, is warranted in order to increase predictive performance. To this end, constructing big data infrastructures improves accessibility of data by using electronic health records, existing research databases, and disease registries. By applying methods such as machine and deep learning, we can model complex interactions, identify new phenotype clusters, and perform prognostic modelling. This review aims to provide an overview of the evolution of DCM definitions as well as its clinical work-up and considerations in the era of genomics. In addition, we present exciting examples in the field of big data infrastructures, personalised prognostic assessment, and artificial intelligence.

SUBMITTER: Sammani A 

PROVIDER: S-EPMC7956169 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Diagnosis and Risk Prediction of Dilated Cardiomyopathy in the Era of Big Data and Genomics.

Sammani Arjan A   Baas Annette F AF   Asselbergs Folkert W FW   Te Riele Anneline S J M ASJM  

Journal of clinical medicine 20210226 5


Dilated cardiomyopathy (DCM) is a leading cause of heart failure and life-threatening ventricular arrhythmias (LTVA). Work-up and risk stratification of DCM is clinically challenging, as there is great heterogeneity in phenotype and genotype. Throughout the last decade, improved genetic testing of patients has identified genotype-phenotype associations and enhanced evaluation of at-risk relatives leading to better patient prognosis. The field is now ripe to explore opportunities to improve perso  ...[more]

Similar Datasets

| S-EPMC4815885 | biostudies-other
| S-EPMC6723049 | biostudies-literature
| S-EPMC8564378 | biostudies-literature
| S-EPMC7288990 | biostudies-literature
| S-EPMC10585513 | biostudies-literature
| S-EPMC9117485 | biostudies-literature
| S-EPMC4988677 | biostudies-literature
| S-EPMC5322656 | biostudies-literature
| S-EPMC8021051 | biostudies-literature
| S-EPMC3332064 | biostudies-literature